ARCHIVES

GAO Criticizes Eppley, NCI For ‘Deficiencies’ In Review, Monitoring, Management of Contract

This article is from The Cancer Letter archive.

Vol. 04 No. 08 | February 24, 1978

Download PDF Visit The Full Archive

Related Articles

Velcade Improves Survival In Relapsed Multiple Myeloma

July 29, 2005

In Brief: French 10 Years Behind In Treatment Techniques, Rauscher Tells Premier; European Interest Grows

September 26, 1975

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

September 26, 2014

NCI-Approved Group, Center Clinical Trials Listed

May 25, 2007

IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed.

April 16, 2010

In Brief: Nabel To Direct Vaccine Research Center; Former NIH Director Robert Marston Is Dead

March 19, 1999